Results 181 to 190 of about 37,039 (220)
Some of the next articles are maybe not open access.
Acta Anaesthesiologica Scandinavica, 2008
Background and aim: Remifentanil is an ultra‐short‐acting opioid, increasingly used today in neuroanesthesia and neurointensive care. Its characteristics make remifentanil a potentially ideal agent, but previous data have cast a shadow on this opioid, supporting potentially toxic effects on the ischemic brain.
FODALE, Vincenzo +3 more
openaire +3 more sources
Background and aim: Remifentanil is an ultra‐short‐acting opioid, increasingly used today in neuroanesthesia and neurointensive care. Its characteristics make remifentanil a potentially ideal agent, but previous data have cast a shadow on this opioid, supporting potentially toxic effects on the ischemic brain.
FODALE, Vincenzo +3 more
openaire +3 more sources
Intensive and Critical Care Nursing, 2002
Remifentanil is a synthetic opioid receptor agonist that was introduced in 1997 for analgesia during general anaesthesia. However, it recently received a license for analgesia and sedation in ventilated intensive care patients and so is now of interest to those working in intensive care.
openaire +3 more sources
Remifentanil is a synthetic opioid receptor agonist that was introduced in 1997 for analgesia during general anaesthesia. However, it recently received a license for analgesia and sedation in ventilated intensive care patients and so is now of interest to those working in intensive care.
openaire +3 more sources
Pediatric Anesthesia, 2010
SummaryRemifentanil has gained the confidence of anesthesiologists and has given a real opportunity to change the way anesthesia is given. It can be considered the ideal opioid despite many obstacles to pediatric use: the condition of ‘off‐label’, the lack of wide randomized clinical trials, and the fear of adverse events because of its high potency ...
Maria, Sammartino +4 more
openaire +2 more sources
SummaryRemifentanil has gained the confidence of anesthesiologists and has given a real opportunity to change the way anesthesia is given. It can be considered the ideal opioid despite many obstacles to pediatric use: the condition of ‘off‐label’, the lack of wide randomized clinical trials, and the fear of adverse events because of its high potency ...
Maria, Sammartino +4 more
openaire +2 more sources
Current Opinion in Anaesthesiology, 2008
The present study summarizes the knowledge to date of the use of remifentanil in obstetric anaesthesia and analgesia.Modest labour analgesia, particularly for the first stage, can be achieved using a patient-controlled analgesia bolus of 40 microg with a 2-min lockout.
openaire +2 more sources
The present study summarizes the knowledge to date of the use of remifentanil in obstetric anaesthesia and analgesia.Modest labour analgesia, particularly for the first stage, can be achieved using a patient-controlled analgesia bolus of 40 microg with a 2-min lockout.
openaire +2 more sources
Remifentanil for Cardiac Anaesthesia
2003Total intravenous anaesthesia (TIVA) incorporating high dose opioid is the mainstay of modern anaesthesia for cardiac surgery. High dose opioids attenuate the sympathetic and somatic responses to noxious stimulation. They have minimal negative effects on the contractility, the coronary circulation and the myocardial metabolism and can be given even in ...
Barvais, Luc, Sutcliffe, Nicholas
openaire +3 more sources
Current Opinion in Anaesthesiology, 2003
Remifentanil has now reached maturity, as reflected by the increasing number of clinical papers relating to its use. Its position among anaesthetic drugs is now better understood, and this review will attempt to place it in the context of current clinical practice.Propofol reduces the initial distribution of remifentanil, leading to higher ...
openaire +2 more sources
Remifentanil has now reached maturity, as reflected by the increasing number of clinical papers relating to its use. Its position among anaesthetic drugs is now better understood, and this review will attempt to place it in the context of current clinical practice.Propofol reduces the initial distribution of remifentanil, leading to higher ...
openaire +2 more sources